CCIA
GILD icon

Cherry Creek Investment Advisors’s Gilead Sciences GILD Stock Holding History

Cherry Creek Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
8,954
+265
+3% +$34.9K 0.45% 45
2026
Q1 		$1.21M Sell
8,689
-15
-0.2% -$2.1K 0.53% 38
2025
Q4 		$1.07M Buy
8,704
+285
+3% +$34.6K 0.46% 41
2025
Q3 		$935K Buy
8,419
+476
+6% +$54.1K 0.4% 43
2025
Q2 		$881K Buy
7,943
+693
+10% +$73.8K 0.41% 43
2025
Q1 		$812K Buy
7,250
+1,950
+37% +$201K 0.42% 41
2024
Q4 		$490K Buy
5,300
+40
+0.8% +$3.6K 0.24% 58
2024
Q3 		$441K Buy
5,260
+317
+6% +$24.2K 0.23% 60
2024
Q2 		$339K Sell
4,943
-1,761
-26% -$118K 0.18% 79
2024
Q1 		$491K Sell
6,704
-79
-1% -$6.08K 0.27% 61
2023
Q4 		$549K Buy
6,783
+54
+0.8% +$4.2K 0.34% 53
2023
Q3 		$504K Buy
6,729
+58
+0.9% +$4.46K 0.34% 51
2023
Q2 		$514K Buy
6,671
+231
+4% +$18.4K 0.35% 50
2023
Q1 		$534K Sell
6,440
-266
-4% -$22K 0.39% 50
2022
Q4 		$576K Sell
6,706
-43
-0.6% -$3.4K 0.45% 49
2022
Q3 		$416K Buy
6,749
+74
+1% +$4.67K 0.34% 52
2022
Q2 		$413K Buy
6,675
+217
+3% +$13.4K 0.33% 56
2022
Q1 		$384K Buy
6,458
+729
+13% +$46.6K 0.25% 69
2021
Q4 		$416K Buy
5,729
+1,027
+22% +$70.7K 0.26% 63
2021
Q3 		$328K Buy
4,702
+132
+3% +$9.27K 0.22% 76
2021
Q2 		$315K Buy
+4,570
New +$305K 0.21% 79

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cherry Creek Investment Advisors's GILD Position: Q2 2026 in Review

Cherry Creek Investment Advisors increased its Gilead Sciences (GILD) stake by 3% in Q2 2026, buying an estimated $34.9K and bringing the position to 8,954 shares worth $1.13M. The position accounts for 0.45% of the portfolio, ranked #45.

Cherry Creek Investment Advisors first reported a position in GILD in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.21M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cherry Creek Investment Advisors held 8,954 shares of Gilead Sciences worth $1.13M as of Q2 2026.
  • Cherry Creek Investment Advisors bought 265 Gilead Sciences shares in Q2 2026, an estimated $34.9K.
  • Gilead Sciences made up 0.45% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #45 holding.
  • Cherry Creek Investment Advisors first reported a position in Gilead Sciences in Q2 2021 and has held it in 21 quarters since.
  • Cherry Creek Investment Advisors's Gilead Sciences position peaked at $1.21M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.